Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
27.7M
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
7.62M
-
Shares change
-
+468K
-
Total reported value, excl. options
-
$92.2M
-
Value change
-
+$5.66M
-
Number of buys
-
12
-
Number of sells
-
-4
-
Price
-
$12.09
Significant Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q1 2018
22 filings reported holding FENC - FENNEC PHARMACEUTICALS INC. - Common Shares as of Q1 2018.
FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) has 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.62M shares
of 27.7M outstanding shares and own 27.53% of the company stock.
Largest 10 shareholders include Southpoint Capital Advisors LP (4M shares), Opaleye Management Inc. (873K shares), 683 Capital Management, LLC (867K shares), EVENTIDE ASSET MANAGEMENT, LLC (741K shares), venBio Select Advisor LLC (273K shares), PUTNAM INVESTMENTS LLC (263K shares), ACUTA CAPITAL PARTNERS, LLC (250K shares), MILLENNIUM MANAGEMENT LLC (92.7K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (56.7K shares), and GRANAHAN INVESTMENT MANAGEMENT INC/MA (47.4K shares).
This table shows the top 20 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.